|
1
|
Broekmans FJ, Soules MR and Fauser BC:
Ovarian aging: Mechanisms and clinical consequences. Endocr Rev.
30:465–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park SU, Walsh L and Berkowitz KM:
Mechanisms of ovarian aging. Reproduction. 162:R19–R33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chon SJ, Umair Z and Yoon MS: Premature
ovarian insufficiency: Past, present, and future. Front Cell Dev
Biol. 9:6728902021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scantamburlo VM, Linsingen RV, Centa LJR,
Toso KFD, Scaraboto D, Araujo Júnior E and Kulak Junior J:
Association between decreased ovarian reserve and poor oocyte
quality. Obstet Gynecol Sci. 64:532–539. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao LN, Lin WQ, Jiang N, Li C, Cao HF, Li
H and Qian JH: Comparative study of assisted reproductive outcomes
between young patients with occult premature ovarian insufficiency
and advanced-age patients. J Int Med Res. 48:3000605209346562020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abrahami N, Izhaki I and Younis JS: Do
young women with unexplained infertility show manifestations of
decreased ovarian reserve? J Assist Reprod Genet. 36:1143–1152.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu T, Li Q, Wang S, Chen C and Zheng J:
Transplantation of ovarian granulosa-like cells derived from human
induced pluripotent stem cells for the treatment of murine
premature ovarian failure. Mol Med Rep. 13:5053–5058. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie Z, Li Y, Chen Z, Cao Q, Zhang C, Fei
Y, Li K and Guan Y: Effects of Bushen Huoxue method for female with
decreased ovarian reserve: A protocol for systematic review and
meta-analysis. Medicine (Baltimore). 99:e229572020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv Z, Lv Z, Song L, Zhang Q and Zhu S:
Role of lncRNAs in the pathogenic mechanism of human decreased
ovarian reserve. Front Genet. 14:10560612023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fusco F, Paciolla M, Chen E, Li X, Genesio
R, Conti A, Jones J, Poeta L, Lioi MB, Ursini MV and Miano MG:
Genetic and molecular analysis of a new unbalanced X;18
rearrangement: Localization of the diminished ovarian reserve
disease locus in the distal Xq POF1 region. Hum Reprod.
26:3186–3196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferder IC, Espeche LD, Bruque CD,
Parborell F, Tesone M and Dain L: Expression and characterisation
of Fmr1 splice variants during folliculogenesis in the rat. Reprod
Fertil Dev. 34:1034–1042. 2022. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paulini F and Melo EO: The role of
oocyte-secreted factors GDF9 and BMP15 in follicular development
and oogenesis. Reprod Domest Anim. 46:354–361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu W, Han J, Cao R, Zhang J, Li B, Liu Z,
Liu K, Li Q, Pan Z, Chen J and Liu H: Sequence and regulation of
the porcine FSHR gene promoter. Anim Reprod Sci. 154:95–104. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gogola J, Hoffmann M and Ptak A:
Persistent endocrine-disrupting chemicals found in human follicular
fluid stimulate the proliferation of granulosa tumor spheroids via
GPR30 and IGF1R but not via the classic estrogen receptors.
Chemosphere. 217:100–110. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henes M, Froeschlin J, Taran FA, Brucker
S, Rall KK, Xenitidis T, Igney-Oertel A, Lawrenz B and Henes JC:
Ovarian reserve alterations in premenopausal women with chronic
inflammatory rheumatic diseases: Impact of rheumatoid arthritis,
Behcet's disease and spondyloarthritis on anti-Mullerian hormone
levels. Rheumatology (Oxford). 54:1709–1712. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Wu S, Wang M, Zhang H and Cui M: A
review of autoimmunity and immune profiles in patients with primary
ovarian insufficiency. Medicine (Baltimore). 101:e325002022.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim Y, Lee E, Song JY, Kim Y and Lee S:
Association between environmental pollutants and the FSH/AMH ratio
as a marker of ovarian reserve. Environ Anal Health Toxicol.
37:e2022029–0. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Osmanlioglu S, Berker B, Aslan B, Şükür
YE, Özmen B, Sönmezer M, Atabekoğlu CS and Aytaç R: Presence of
endometrioma does not impair embryo quality and assisted
reproductive technology (ART) cycle outcome in diminished ovarian
reserve (DOR) patients. Reprod Sci. 30:1540–1547. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vigneswaran K and Hamoda H: Hormone
replacement therapy-Current recommendations. Best Pract Res Clin
Obstet Gynaecol. 81:8–21. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gonda KJ, Domar AD, Gleicher N and Marrs
RP: Insights from clinical experience in treating IVF poor
responders. Reprod Biomed Online. 36:12–19. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monteiro CS, Scheffer BB, Carvalho RF and
Scheffer JB: The impact of dehydroepiandrosterone in poor ovarian
responders on assisted reproduction technology treatment. JBRA
Assist Reprod. 23:414–417. 2019.PubMed/NCBI
|
|
22
|
Pellicer N, Cozzolino M, Diaz-Garcia C,
Galliano D, Cobo A, Pellicer A and Herraiz S: Ovarian rescue in
women with premature ovarian insufficiency: Facts and fiction.
Reprod Biomed Online. 46:543–565. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen H, Liu C, Zhu S, Li S, Zhang Q, Song
L and Liang X: The therapeutic effect of stem cells on
Chemotherapy-Induced premature ovarian failure. Curr Mol Med.
21:376–384. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu JJ, Zhang J, Xia CY, Ding K, Li XX, Pan
XG, Xu JK, He J and Zhang WK: Hypericin: A natural anthraquinone as
promising therapeutic agent. Phytomedicine. 111:1546542023.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Fan G, Wei F, Bu Y and Huang W:
Hyperoside protects rat ovarian granulosa cells against hydrogen
peroxide-induced injury by sonic hedgehog signaling pathway. Chem
Biol Interact. 310:1087592019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu F, Gao J, Zeng F, Lai Y, Ruan X and
Deng G: Hyperoside protects against cyclophosphamide induced
ovarian damage and reduced fertility by suppressing
HIF-1alpha/BNIP3-mediated autophagy. Biomed Pharmacother.
156:1137432022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
You F, Cao J, Cheng L, Liu X and Zeng L:
Hyperin alleviates Triptolide-induced ovarian granulosa cell injury
by regulating AKT/TSC1/mTORC1 signaling. Evid Based Complement
Alternat Med. 2021:93992612021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan W, Gu L, Yang H, Xu C, Yang Z, Lu Q,
Shi Y, Zhang L, Shao J, Chen Y, et al: Repeat-dose toxicity study
of human umbilical cord mesenchymal stem cells in cynomolgus
monkeys by intravenous and subcutaneous injection. Front Cell Dev
Biol. 11:12737232023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Council NR: Guide for the Care and Use of
Laboratory Animals: Eighth Edition. Washington, DC: The National
Academies Press; 2011
|
|
31
|
Huang C, Song K, Ma W, Ding J, Chen Z and
Zhang M: Immunomodulatory mechanism of Bushen Huoxue Recipe
alleviates cyclophosphamide-induced diminished ovarian reserve in
mouse model. J Ethnopharmacol. 208:44–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Byers SL, Wiles MV, Dunn SL and Taft RA:
Mouse estrous cycle identification tool and images. PLoS One.
7:e355382012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ajayi AF and Akhigbe RE: Staging of the
estrous cycle and induction of estrus in experimental rodents: An
update. Fertil Res Pract. 6:52020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Q, Chen Q, Song Y, Xiang Y, Li Q,
Sang Y, Zhang L, Bai L and Zhu Y: Downregulation of homeobox A1 in
human granulosa cells is involved in diminished ovarian reserve
through promoting cell apoptosis and mitochondrial dysfunction. Mol
Cell Endocrinol. 580:1120842024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cedars MI: Managing poor ovarian response
in the patient with diminished ovarian reserve. Fertil Steril.
117:655–656. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wierman ME and Kiseljak-Vassiliades K:
Should dehydroepiandrosterone be administered to Women? J Clin
Endocrinol Metab. 107:1679–1685. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Somigliana E, Li Piani L, Paffoni A,
Salmeri N, Orsi M, Benaglia L, Vercellini P and Vigano' P:
Endometriosis and IVF treatment outcomes: Unpacking the process.
Reprod Biol Endocrinol. 21:1072023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang C and Xu X: Advancement in the
treatment of diminished ovarian reserve by traditional Chinese and
Western medicine. Exp Ther Med. 11:1173–1176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Buigues A, Marchante M, Herraiz S and
Pellicer A: Diminished ovarian reserve Chemotherapy-induced mouse
model: A tool for the preclinical assessment of new therapies for
ovarian damage. Reprod Sci. 27:1609–1619. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He R, Fan Q, Li Y, Zhu Q, Hu D, Du J, Xing
Y, Li H, Liang X and Yang Y: Identification of common and specific
genes involved in mouse models of Age-related and
Cyclophosphamide-Induced diminished ovarian reserve. Reprod Sci.
30:1965–1978. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bunnewell SJ, Honess ER, Karia AM, Keay
SD, Al Wattar BH and Quenby S: Diminished ovarian reserve in
recurrent pregnancy loss: A systematic review and meta-analysis.
Fertil Steril. 113:818–827.e3. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kučera M, Štěpán Ml J and Štelcl M:
Possibilities and real meaning of assessment of ovarian reserve.
Ceska Gynekol. 83:307–311. 2018.PubMed/NCBI
|
|
43
|
Chhabra V, Meenakshi S, Maity S, Saini D,
Saini M, Murti K and Kumar N: Impact of fluoride exposure on
reproductive health: Insights into molecular mechanisms and health
implications. Reprod Toxicol. 135:1089072025. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nazeerulla F, Banerjee I, Paul MK, Bisht
B, Basu D, Bhutia SK and Mukhopadhyay S: Autophagy as an architect
of embryogenesis: Understanding the new mechanisms, emerging
paradigms, and future directions. Life Sci. 391:1242772026.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Debnath J, Gammoh N and Ryan KM: Autophagy
and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol.
24:560–575. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kawano M, McKey J, Batchvarov IS and Capel
B: Granulosa cell death is a significant contributor to
DNA-damaging chemotherapy-induced ovarian insufficiencydagger. Biol
Reprod. 112:906–915. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu F, Hu C, Huang S, Cao X, Li X, Song Y,
Chen M and Xiao J: Qilin Pills protect against diminished ovarian
reserve by suppressing pathological overactivation of
PINK1/Parkin-mediated mitophagy in granulosa cells. J
Ethnopharmacol. 369:1218622026. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen L, Zeng L, Pan S, Zu L, Pan H and Fan
L: β-sitosterol in Yijing Hugui decoction prevents
cyclophosphamide-induced premature ovarian insufficiency via the
AKT1/Nrf2 pathway. Cytotechnology. 77:762025. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kimiz-Gebologlu I and Oncel SS: Exosomes:
Large-scale production, isolation, drug loading efficiency, and
biodistribution and uptake. J Control Release. 347:533–543. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liang Y, Duan L, Lu J and Xia J:
Engineering exosomes for targeted drug delivery. Theranostics.
11:3183–3195. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou Q, Tang H, Wang Y, Hua Y, Ouyang X
and Li L: Hyperoside mitigates PCOS-associated adipogenesis and
insulin resistance by regulating NCOA2-mediated PPAR-gamma
ubiquitination and degradation. Life Sci. 364:1234172025.
View Article : Google Scholar : PubMed/NCBI
|
